Found: 8
Select item for more details and to access through your institution.
Targeting senescent cells in translational medicine.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 12, p. N.PAG, doi. 10.15252/emmm.201810234
- By:
- Publication type:
- Article
A versatile drug delivery system targeting senescent cells.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 9, p. 1, doi. 10.15252/emmm.201809355
- By:
- Publication type:
- Article
Anti‐oncostatin M antibody inhibits the pro‐malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
- Published in:
- Journal of Pathology, 2018, v. 244, n. 3, p. 283, doi. 10.1002/path.5010
- By:
- Publication type:
- Article
Aflibercept and Ang1 supplementation improve neoadjuvant or adjuvant chemotherapy in a preclinical model of resectable breast cancer.
- Published in:
- Scientific Reports, 2016, p. 36694, doi. 10.1038/srep36694
- By:
- Publication type:
- Article
Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 282, p. 1, doi. 10.1126/scitranslmed.3010722
- By:
- Publication type:
- Article
Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0158034
- By:
- Publication type:
- Article
Galacto‐conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity.
- Published in:
- Aging Cell, 2020, v. 19, n. 4, p. 1, doi. 10.1111/acel.13142
- By:
- Publication type:
- Article